Consolidated Balance Sheets - USD ($)	Jan. 31, 2023	Jul. 31, 2022
Current Assets
Cash	$ 9,553	$ 718
Loan receivable	453,690	336,480
Total Current Assets	463,243	337,198
Construction in progress	159,958	0
Investment	1,945,200	0
TOTAL ASSETS	2,568,401	337,198
Current Liabilities
Accounts payable and accrued liabilities	94,449	13,075
Deferred interest income	0	6,748
Due to related parties	2,238,592	8,812
Total Current Liabilities	2,333,041	28,635
TOTAL LIABILITIES	2,333,041	28,635
Stockholders' Equity
Common stock: 300,000,000 authorized; $0.001 par value 595,986 shares issued and outstanding	596	596
Additional paid in capital	331,105	331,105
Accumulated deficit	(96,441)	(23,238)
Total Stockholders' Equity	235,360	308,563
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	2,568,401	337,198
Series A Preferred Stock [Member]
Stockholders' Equity
Preferred stock: 10,000,000 authorized; $0.001 par value, Series A preferred stock 100,000 designated; $0.001 par value, 100,000 shares issued and outstanding	$ 100	$ 100

Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.

Name:	us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.